Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Oct;61(10):1514-5.
doi: 10.1136/gutjnl-2012-301994. Epub 2012 Jul 31.

HCCR-1 for detecting small hepatocellular carcinoma latent in a cirrhotic liver: a prospective cohort study

Peng Jirun, Guoxin Zhang, Seon-Ah Ha, Hyun Kee Kim, Jinah Yoo, Sanghee Kim, Jin Zhongtian, Cui Zhuqingqing, Youn Soo Lee, Gi Hwan Gong, Joo Hee Yoon, Hae Nam Lee, Sa Jin Kim, Tae Eung Kim, Eun Young Song, Yun Kyung Lee, Yong Gyu Park, Jin Woo Kim
Free PMC article
Comment

HCCR-1 for detecting small hepatocellular carcinoma latent in a cirrhotic liver: a prospective cohort study

Peng Jirun et al. Gut. 2012 Oct.
Free PMC article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Figures

Figure 1
Figure 1
ROC curves comparing AFP, DCP and HCCR-1 in patients with HCC (Panel A) or small HCC (Panel B) versus those with non-malignant liver disease. The curves show the optimal cut-off value for AFP of 10 ng/ml, for DCP of 22 mAU/ml, and for HCCR-1 of 1.96 ng/ml. The area under the ROC curve is shown with its 95% confidence. AFP is blue, DCP is brown, HCCR-1 is green, and AFP + HCCR-1 + and DCP is purple. The number of cases for each group used in this ROC curve analyses is 612 (HCC), 131 (early HCC) and 1010 (those with non-malignant disease). AUC, Area Under the Curve.
See this image and copyright information in PMC

Comment on

References

    1. Tremosini S, Forner A, Boix L, et al. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut. Published Online First: 27 January 2012. doi:10.1136/gutjnl-2011-301951 - DOI - PubMed
    1. Rimola J, Forner A, Tremosini S, et al. Non-invasive diagnosis of hepatocellular carcinoma <2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 2012;56:1317–23 - PubMed
    1. Ko J, Lee YH, Hwang SY, et al. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene 2003;22:4679–89 - PubMed
    1. Yoon SK, Lim NK, Ha SA, et al. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma. Cancer Res 2004;64:5434–41 - PubMed